These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Update on therapy of diabetes mellitus: diet, sulfonylurea agents, and insulin. Davidson MB Mt Sinai J Med; 1987 Mar; 54(3):199-210. PubMed ID: 3295527 [No Abstract] [Full Text] [Related]
23. Treatment with glibenclamide in maturity-onset diabetes mellitus. Persson I; Madsen SN Geriatrics; 1971 May; 26(5):182-95. PubMed ID: 5004113 [No Abstract] [Full Text] [Related]
24. [The treatment characteristics of non-insulin-dependent diabetes mellitus]. Balabolkin MI; Kreminskaia VM Ter Arkh; 1996; 68(10):5-11. PubMed ID: 9026945 [No Abstract] [Full Text] [Related]
25. Influence of glycemic control on the development of diabetic cardiovascular and kidney disease. Saha SA; Tuttle KR Cardiol Clin; 2010 Aug; 28(3):497-516. PubMed ID: 20621253 [TBL] [Abstract][Full Text] [Related]
26. [Treatment of diabetes mellitus with oral antidiabetics]. Froesch ER Schweiz Med Wochenschr; 1976 Nov; 106(48):1665-7. PubMed ID: 827809 [No Abstract] [Full Text] [Related]
27. [Evaluation of a new sulfonylurea, glipizide, in the treatment of diabetes mellitus]. Ninni M; Castelletta L Minerva Med; 1973 Oct; 64(71):3725-31. PubMed ID: 4588364 [No Abstract] [Full Text] [Related]
28. Drugs for type 2 diabetes. Treat Guidel Med Lett; 2008 Jul; 6(71):47-54. PubMed ID: 18583949 [No Abstract] [Full Text] [Related]
29. [Differential treatment of patients with newly detected diabetes mellitus]. Pan'kiv VI Vrach Delo; 1985 Oct; (10):8-10. PubMed ID: 3911579 [No Abstract] [Full Text] [Related]
34. [Indication and method of administration of oral antidiabetic agents]. Tasaka Y Nihon Rinsho; 1997 Nov; 55 Suppl():99-103. PubMed ID: 9434451 [No Abstract] [Full Text] [Related]
35. [Behavior of serum insulin under the influence of glisoxepide with and without butylbiguanide]. Birk W; Petrides P Arzneimittelforschung; 1974 Mar; 24(0):425-9. PubMed ID: 4408033 [No Abstract] [Full Text] [Related]
36. [Late failures of oral therapy of diabetes]. Kaeding A; Werner P Dtsch Z Verdau Stoffwechselkr; 1965 Nov; 25(5):305-12. PubMed ID: 5888991 [No Abstract] [Full Text] [Related]
37. Clinical experience with glynclamide, a new hypoglycaemic agent. Burns FH Med J Aust; 1969 Aug; 2(9):436-9. PubMed ID: 4898056 [No Abstract] [Full Text] [Related]
38. [Results in diabetic therapy with Silubin retard. 3]. Kopp H Med Klin; 1971 Feb; 66(7):246-7. PubMed ID: 5552720 [No Abstract] [Full Text] [Related]
39. Oral hypoglycemic agents in type II diabetes mellitus. Lubbos H; Miller JL; Rose LI Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707 [TBL] [Abstract][Full Text] [Related]
40. [Our experiences with Tolbutaphenone in the treatment of diabetes mellitus]. Grujić M; Perinović M; Rizvanbegović B Med Arh; 1977; 31(2):97-100. PubMed ID: 904375 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]